ES2115733T3 - Composicion antialergica para uso oftalmico o nasal. - Google Patents

Composicion antialergica para uso oftalmico o nasal.

Info

Publication number
ES2115733T3
ES2115733T3 ES93310464T ES93310464T ES2115733T3 ES 2115733 T3 ES2115733 T3 ES 2115733T3 ES 93310464 T ES93310464 T ES 93310464T ES 93310464 T ES93310464 T ES 93310464T ES 2115733 T3 ES2115733 T3 ES 2115733T3
Authority
ES
Spain
Prior art keywords
composition
ophthalmic
antialergic
nasal use
nasal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93310464T
Other languages
English (en)
Inventor
Yoshifumi Ikejiri
Takahiro Ogawa
Fuminori Tokumochi
Shogo Sameshima
Motoko Kimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Farchim SA
Original Assignee
Farchim SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farchim SA filed Critical Farchim SA
Application granted granted Critical
Publication of ES2115733T3 publication Critical patent/ES2115733T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE DESCRIBE AQUI UNA COMPOSICION ANTIALERGICA PARA USO NASAL U OFTALMICO, QUE COMPRENDE CETERICINA O UNA SAL DE LA MISMA COMO INGREDIENTE ACTIVO. LA COMPOSICION ANTIALERGICA PUEDE CONTENER ADEMAS UN COMPUESTO DE CICLODEXTRINA, ASI COMO UN AGENTE TENSOACTIVO Y/O UN POLIMERO SOLUBLE EN AGUA.
ES93310464T 1992-12-25 1993-12-23 Composicion antialergica para uso oftalmico o nasal. Expired - Lifetime ES2115733T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34603192 1992-12-25

Publications (1)

Publication Number Publication Date
ES2115733T3 true ES2115733T3 (es) 1998-07-01

Family

ID=18380671

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93310464T Expired - Lifetime ES2115733T3 (es) 1992-12-25 1993-12-23 Composicion antialergica para uso oftalmico o nasal.

Country Status (23)

Country Link
US (1) US5419898A (es)
EP (1) EP0605203B1 (es)
JP (1) JP3683595B2 (es)
KR (1) KR100276743B1 (es)
CN (1) CN1050514C (es)
AT (1) ATE164068T1 (es)
AU (1) AU666413B2 (es)
BG (1) BG61101B1 (es)
CA (1) CA2112014C (es)
CZ (1) CZ283029B6 (es)
DE (1) DE69317537T2 (es)
DK (1) DK0605203T3 (es)
ES (1) ES2115733T3 (es)
FI (1) FI111805B (es)
HU (2) HU218672B (es)
LT (1) LT3344B (es)
LV (1) LV10688B (es)
NO (2) NO304176B1 (es)
NZ (1) NZ250519A (es)
PL (1) PL173347B1 (es)
RU (1) RU2130774C1 (es)
SK (1) SK279503B6 (es)
TW (1) TW401300B (es)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897858A (en) * 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
EP0780127A1 (en) * 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
AU714913B2 (en) * 1996-09-27 2000-01-13 Nastech Pharmaceutical Company, Inc. Intranasal formulations for promoting sleep and method of using the same
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
EP0919550A1 (en) 1997-11-26 1999-06-02 Ucb, S.A. Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
JP2002523475A (ja) 1998-09-02 2002-07-30 アラーガン・セイルズ・インコーポレイテッド 防腐したシクロデキストリン含有組成物
BR9804993A (pt) * 1998-11-10 2000-06-06 Panacea Biotec Ltd Composição antialérgica e antiinflamatória
JP2001125052A (ja) * 1999-10-25 2001-05-11 Lion Corp コンタクトレンズ装着液
US6258814B1 (en) * 2000-10-13 2001-07-10 Schering Corporation Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep
CN101632642B (zh) * 2002-01-15 2011-06-08 Ucb法奇姆股份有限公司 口感和稳定性改善的配方
US20070092582A1 (en) * 2002-01-18 2007-04-26 Fu-Pao Tsao Methods of preserving ophthalmic solutions and preserved ophthalmic solutions
JP4543274B2 (ja) * 2002-10-01 2010-09-15 大正製薬株式会社 点鼻剤組成物
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20050255154A1 (en) * 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
WO2005115345A1 (en) * 2004-05-28 2005-12-08 Imaginot Pty Ltd Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
JP2006008568A (ja) * 2004-06-24 2006-01-12 Cyclochem:Kk ＩｇＥ抗体抑制剤および食品
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
CA2574602A1 (en) * 2004-07-22 2006-02-02 Pfizer Products Inc. Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form
US7973025B2 (en) 2005-05-26 2011-07-05 Neuron Systems, Inc. Compositions and methods of treating retinal disease
JPWO2006137433A1 (ja) * 2005-06-21 2009-01-22 わかもと製薬株式会社 レボカバスチンを可溶化させた水性薬剤
EP3263117A1 (en) * 2005-11-28 2018-01-03 Imaginot Pty Ltd. Oral therapeutic compound delivery system
JPWO2007105691A1 (ja) * 2006-03-13 2009-07-30 株式会社アールテック・ウエノ 水性組成物
WO2008025560A1 (en) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
CN101284026B (zh) * 2007-04-12 2010-11-10 鲁南制药集团股份有限公司 一种用于治疗皮肤过敏性疾病的药物组合物
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
US9358242B2 (en) * 2007-08-30 2016-06-07 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
EP2408453B1 (en) * 2009-03-17 2022-01-05 Nicox Ophthalmics, Inc. Ophthalmic formulations of cetirizine and methods of use
US8569273B2 (en) * 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US8263581B2 (en) * 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
WO2011017909A1 (zh) * 2009-08-12 2011-02-17 鲁南贝特制药有限公司 盐酸西替利嗪的药物溶液
JP5702795B2 (ja) 2009-11-06 2015-04-15 イェール ユニバーシティーＹａｌｅ Ｕｎｉｖｅｒｓｉｔｙ 両親媒性化合物ならびにその調製および使用方法
WO2011072141A1 (en) 2009-12-11 2011-06-16 Neuron Systems, Inc. Compositions and methods for the treatment of macular degeneration
HRP20200567T1 (hr) * 2011-11-29 2020-06-26 Jurox Pty Ltd Stabilni injektabilni farmaceutski pripravci koji sadrže 2-hidroksipropil-beta-ciklodekstrin i alfaksalon
SG11201505587YA (en) 2013-01-23 2015-08-28 Aldeyra Therapeutics Inc Toxic aldehyde related diseases and treatment
AU2016311158A1 (en) 2015-08-21 2018-04-05 Aldeyra Therapeutics, Inc. Deuterated compounds and uses thereof
EP3419633A4 (en) * 2016-02-28 2019-10-30 Aldeyra Therapeutics, Inc. TREATMENT OF ALLERGIC EYE DISEASES WITH CYCLODEXTRINS
WO2017196881A1 (en) 2016-05-09 2017-11-16 Aldeyra Therapeutics, Inc. Combination treatment of ocular inflammatory disorders and diseases
US11241426B2 (en) 2017-02-13 2022-02-08 Nitto Medic Co., Ltd. Aqueous composition for ophthalmic or nasal administration
CA3054811A1 (en) 2017-03-16 2018-09-20 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
MX2020003425A (es) 2017-10-10 2020-07-29 Aldeyra Therapeutics Inc Tratamiento de trastornos inflamatorios.
PT3740191T (pt) * 2018-01-18 2021-07-09 Faes Farma Sa Composições oftálmicas compreendendo bilastina, uma beta-ciclodextrina e pelo menos um agente gelificante
EP3833660A4 (en) 2018-08-06 2022-05-11 Aldeyra Therapeutics, Inc. POLYMORPHIC COMPOUNDS AND THEIR USES
JP7505786B2 (ja) 2018-09-25 2024-06-25 アルデイラ セラピューティクス， インコーポレイテッド ドライアイ疾患を処置するための製剤
JP7706758B2 (ja) 2019-03-26 2025-07-14 アルデイラ セラピューティクス， インコーポレイテッド 眼科用製剤およびその使用
EP3725298A1 (en) * 2019-04-16 2020-10-21 Faes Farma, S.A. Stable and preserved pharmaceutical compositions of bilastine
JP2022530967A (ja) 2019-05-02 2022-07-05 アルデイラ セラピューティクス， インコーポレイテッド 多形化合物およびその使用
US12098132B2 (en) 2019-05-02 2024-09-24 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
CA3175856A1 (en) 2020-05-13 2021-11-18 Todd Brady Pharmaceutical formulations and uses thereof
CN120437087A (zh) 2024-02-01 2025-08-08 科赴品牌有限责任公司 一种口腔溶解膜制剂、其用途及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
US4556660A (en) * 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
AU636685B2 (en) * 1989-12-18 1993-05-06 Alcon Laboratories, Inc. Compositions of antiallergics and antihistamines and methods for their use
US5192780A (en) * 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
DE9015551U1 (de) * 1990-11-14 1992-03-12 Röhm GmbH, 6100 Darmstadt Orale Arzneiform und Überzugsmittel, enthaltend ein im Colon abbaubares Polysaccarid
JPH06311353A (ja) 1993-04-19 1994-11-04 Brother Ind Ltd カラー画像形成装置
JP2619828B2 (ja) 1996-06-17 1997-06-11 九州日立マクセル株式会社 電動式爪みがき機

Also Published As

Publication number Publication date
HUT69385A (en) 1995-09-28
KR100276743B1 (ko) 2001-01-15
NO934630L (no) 1994-06-27
HU218672B (hu) 2000-10-28
US5419898A (en) 1995-05-30
DE69317537T2 (de) 1998-07-09
LV10688B (en) 1995-10-20
FI935851L (fi) 1994-06-26
LTIP1669A (en) 1994-10-25
CN1050514C (zh) 2000-03-22
HU9303746D0 (en) 1994-04-28
EP0605203B1 (en) 1998-03-18
TW401300B (en) 2000-08-11
NO304176B1 (no) 1998-11-09
JPH06239748A (ja) 1994-08-30
DK0605203T3 (da) 1998-12-07
SK279503B6 (sk) 1998-12-02
NZ250519A (en) 1995-03-28
EP0605203A2 (en) 1994-07-06
ATE164068T1 (de) 1998-04-15
HU211972A9 (en) 1996-01-29
EP0605203A3 (en) 1994-11-02
SK147493A3 (en) 1994-07-06
FI111805B (fi) 2003-09-30
RU2130774C1 (ru) 1999-05-27
LV10688A (lv) 1995-06-20
BG98327A (bg) 1994-08-30
AU666413B2 (en) 1996-02-08
FI935851A0 (fi) 1993-12-23
CZ283693A3 (en) 1994-07-13
CA2112014A1 (en) 1994-06-26
NO934630D0 (no) 1993-12-15
CN1094614A (zh) 1994-11-09
LT3344B (en) 1995-07-25
AU5259793A (en) 1994-07-07
PL173347B1 (pl) 1998-02-27
PL301588A1 (en) 1994-06-27
CZ283029B6 (cs) 1997-12-17
BG61101B1 (bg) 1996-11-29
DE69317537D1 (de) 1998-04-23
JP3683595B2 (ja) 2005-08-17
CA2112014C (en) 2004-11-02
KR940013511A (ko) 1994-07-15

Similar Documents

Publication Publication Date Title
ES2115733T3 (es) Composicion antialergica para uso oftalmico o nasal.
ES2123323T3 (es) Asociacion de un compuesto con actividad antimicrobiana (por ejemplo lipoaminoacido n,n-octanoilglicina) y de un monoalquileter de glicerol y su uso como agente antimicrobiano.
ES2133130B1 (es) Nueva formulacion de budesonida, su uso y recipiente que la contiene.
PT698393E (pt) Agente de solubilizacao e preparacao para uso externo contendo o mesmo
BR9509183A (pt) Agente antiinflamatório para uso externo
AR011846A1 (es) Una composicion farmaceutica, y el procedimiento para prepararla
BR9400484A (pt) Agente fungicida, processo para o combate de fungos, uso e processo para a preparação de agentes fungicidas
DE69032848D1 (de) Dosierungsmittel und dessen Verwendung
BRPI9911849B8 (pt) composição espumante para a lavagem e o tratamento dos cabelos e/ou do couro cabeludo.
CA2139381A1 (en) Guar as drift control agent
BR9000729A (pt) Desinfetante pulverizavel para superficies; agente desinfetante
ES2046852T3 (es) Un procedimiento para preparar un champu.
ES2179103T3 (es) Composicion detergente.
AU1264295A (en) Anatomical and biological preservative and improved embalming composition and method
MX9205384A (es) Dispositivo de administracion transdermica de un agente activo para uso veterinario.
BR9713800A (pt) Composição de limpeza abrasiva aquosa antibacteriana.
ES2180774T3 (es) La utilizacion de triacetato de glicerilo para el tratamiento de onicomicosis.
ES2060293T3 (es) Nueva sustancia antiulcerosa.
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
DE59301120D1 (de) Zubereitung zur topischen anwendung.
ES2152315T3 (es) Xamoneline tartrato.
BR9915292A (pt) Associação, utilização de riluzol e composição farmacêutica.
AU4975700A (en) Absorbent article comprising topsheet with low surfactant or no synthetic surfactant
ES8704738A1 (es) Procedimiento para estabilizar y-0 aumentar el efecto microbicida de soluciones acuosas de h2o2
MX9703839A (es) Soluciones intravenosas de lubeluzol.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 605203

Country of ref document: ES